These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35432539)
1. Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature. Lu L; Zhang P; Cao X; Guan M J Oncol; 2022; 2022():1539659. PubMed ID: 35432539 [TBL] [Abstract][Full Text] [Related]
2. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma. Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904 [TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
5. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Li Z; Shen L; Li Y; Shen L; Li N Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984 [TBL] [Abstract][Full Text] [Related]
6. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma. Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376 [TBL] [Abstract][Full Text] [Related]
7. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
8. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
9. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer. Zhuang Z; Cai H; Lin H; Guan B; Wu Y; Zhang Y; Liu X; Zhuang J; Guan G J Oncol; 2021; 2021():5818512. PubMed ID: 34840571 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J Front Genet; 2022; 13():838624. PubMed ID: 35928454 [TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related]
14. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. Wang L; Wang L; He P Front Genet; 2022; 13():1064432. PubMed ID: 36568383 [No Abstract] [Full Text] [Related]
17. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
18. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma. Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527 [TBL] [Abstract][Full Text] [Related]
19. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma. Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808 [No Abstract] [Full Text] [Related]
20. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]